Medical Device | June 30, 2022
NADMED brings first CE-marked NAD+ analysis kit to the market
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
Medidata Detect and Rave CTMS Have Improved Study Execution Through Role-Based Monitoring Workflows and Clinical Data Visualization for Hundreds of Customers Across More Than 9,000 Studies
Bringing next-gen cannabinoid therapeutics to cancer patients
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
Group 4 Medulloblastoma is a rare disease that mostly affects pediatric patients, in which aberrant SRC signaling was identified as a hallmark of the disease
Cantourage introduces second Clever Leaves medical cannabis product to the German market
Efgartigimod is approved in the United States as VYVGART for the treatment of adults with generalized myasthenia gravis
New Regional Processing Lab will serve Ahmedabad and the state of Gujarat
The company has posted net loss of Rs. 67.65 crores for the Financial Year ended March 31, 2022
To address the preventive & primary healthcare delivery gaps in India
Subscribe To Our Newsletter & Stay Updated
